Funding, disease area, and internal validity of hepatobiliary randomized clinical trials
The American Journal of GastroenterologyPublished 1 November 2002
Lise Lotte Kjaergard, Christian Gluud
Citations30
SJR quartileQ1
SJR score2.34
SNIP2.27
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Irrespective of funding, the disease area was significantly associated with the methodological quality and sample size, and external funding and the Disease area are significant predictors of the internal validity of hepatobiliary randomized clinical trials.
Abstract
External funding was significantly associated with adequate methodological quality, but not with the sample size. Irrespective of funding, the disease area was significantly associated with the methodological quality and sample size. Accordingly, external funding and the disease area are significant predictors of the internal validity of hepatobiliary randomized clinical trials.
Keywords
Decision SciencesEconomics, Econometrics and FinanceHealth Professions
BMJEvidence based medicine: what it is and what it isn't
15,683 Citations1996David L. Sackett, William Rosenberg +3 more
As evidence based medicine continues to evolve and adapt, now is a useful time to refine the discussion of what it is andWhat it is not.
JAMAEmpirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
5,580 Citations1995Klaus‐Peter Schulz
Empirical evidence is provided that inadequate methodological approaches in controlled trials, particularly those representing poor allocation concealment, are associated with bias.
The LancetDoes quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
3,591 Citations1998David Moher, Ba’ Pham +6 more
Study of low methodological quality in which the estimate of quality is incorporated into the meta-analyses can alter the interpretation of the benefit of intervention, whether a scale or component approach is used in the assessment of trial quality.
BMJAssessing the quality of controlled clinical trials
3,334 Citations2001Peter Jüni, Douglas G Altman +1 more
The concept of study quality and the methods used to assess quality are discussed and the methodology for both the assessment of quality and its incorporation into systematic reviews and meta-analysis is discussed.
JAMAUsers' guides to the medical literature
2,981 Citations1993Gordon Guyatt
A 55-year-old man who had his serum cholesterol level measured at a shopping mall 2 months ago has an elevated cholesterol level, but before deciding on a treatment recommendation, you elect to find out just how big a reduction in the risk of CHD this patient could expect from a cholesterollowering diet or drug therapy.
Annals of Internal MedicineReported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses
2,326 Citations2001Lise Lotte Kjaergard, John Villumsen +1 more
The potential association between reported methodologic quality and intervention effects was studied to assess whether methodologicquality may explain discrepancies between the results of large and small randomized trials in meta-analyses.
JAMAThe Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1,983 Citations1999Peter Jüni
The data indicate that the use of summary scores to identify trials of high quality is problematic, and relevant methodological aspects should be assessed individually and their influence on effect sizes explored.
Controlled Clinical TrialsAssessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists
1,304 Citations1995David Moher, Alejandro R. Jadad +4 more
An annotated bibliography of scales and checklists developed to assess quality is presented, giving readers a quantitative index of the likelihood that the reported methodology and results are free of bias.
JAMAUsers' Guides to the Medical Literature
947 Citations1993Gordon Guyatt
An internal medicine resident in a rheumatology rotation and seeing a 19-year-old woman who has had systemic lupus erythematosus diagnosed on the basis of a characteristic skin rash, arthritis, and renal disease is distressed by the rising creatinine level.
JAMAUsers' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group
799 Citations1993Gordon Guyatt
A 19-year-old woman who has had systemic lupus erythematosus diagnosed on the basis of a characteristic skin rash, arthritis, and renal disease is seeing an internal medicine resident in a rheumatology rotation.
BMJThe unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials
773 Citations1998Regina Kunz, Andrew D Oxman
On average, failure to use randomisation or adequate concealment of allocation resulted in larger estimates of effect due to a poorer prognosis in non-randomlyselected control groups compared with randomly selected control groups.
The LancetThe uncertainty principle and industry-sponsored research
488 Citations2000Benjamin Djulbegović, M. Lacevic +6 more
The quality of 136 published randomised trials that focused on one disease category (multiple myeloma) and adherence to the uncertainty principle were examined, and the reported bias in research sponsored by the pharmaceutical industry may be a consequence of violations of that principle.
BMJAssociation between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ
432 Citations2002Lise Lotte Kjaergard, Bodil Als-Nielsen
Authors' conclusions in randomised clinical trials significantly favoured experimental interventions if financial competing interests were declared, and were significantly more positive towards the experimental intervention in trials funded by for profit organisations alone compared with trials without competing interests.
How to Use an Article About Therapy or Prevention
354 Citations1995Gordon Guyatt, David L. Sackett +1 more
A 19 year-old woman who has had systemic lupus erythematosus diagnosed on the basis of a characteristic skin rash, arthritis, and renal disease is seeing an internal medicine resident in a rheumatology rotation.
BMJTrials: the next 50 years
244 Citations1998R Peto, Colin Baigent
It is shown that even when large scale randomised evidence is available, wrong conclusions can be drawn from unduly selective emphasis on particular trials or subgroups—and such “selection biases” can cause even greater errors when there is only a limited amount of evidence to review.
Statistics in MedicineAvoidance of large biases and large random errors in the assessment of moderate treatment effects: The need for systematic overviews
181 Citations1987Rory Collins, Richard Gray +2 more
Future trials should take into account the results of any relevant overviews in their design, and should plan to obtain sufficient numbers of events to contribute substantially to such overviews, which implies the need for randomized trials that are much larger than is currently standard.
HepatologyRandomized clinical trials in Hepatology: Predictors of quality
118 Citations1999Lise Lotte Kjaergard, Dimitrinka Nikolova +1 more
The main conclusions are that the quality of RCTs in Hepatology needs improvement and that the probability of high quality increased with the number of centers involved and external funding.
Cochrane Database of Systematic ReviewsColchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis
100 Citations2005Alessandro Rambaldi, Christian Gluud
Combining the results of 14 randomised clinical trials including 1150 patients demonstrated no significant effects of colchicine on mortality, clinical symptoms and complications, liver biochemistry, liver fibrosis markers, liver histology, alcohol consumption, quality of life, and health economics in patients with alcoholic and non-alcoholic fibrosis or cirrhosis.
BMJInterferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials
96 Citations2001LL Kjaergard, Kim Krogsgaard +1 more
Treatment with interferon alfa plus ribavirin has a significant beneficial effect on the virological and histological responses of patients with chronic hepatitis C, irrespective of previous treatment.
UCL Discovery (University College London)Methodology and reviews of clinical trials in portal hypertension
62 Citations1987AK Burroughs
This work presents a meta-analysis of clinical trials in portal hypertension using a novel approach called “big data” to assess the impact of data collection and interpretation on quality and efficiency.
Journal of HepatologyQuality assessment of reports on clinical trials in the Journal of Hepatology
57 Citations1998Christian Gluud, Dimitrinka Nikolova
Many important randomised clinical trials are published in the Journal of Hepatology, but there seems to be ample room for improvement of quality of reporting.
Cochrane Database of Systematic ReviewsEmergency sclerotherapy versus medical interventions for bleeding oesophageal varices in cirrhotic patients
37 Citations2002Gennaro D’Amico, Luigi Pagliaro +2 more
No convincing evidence is found to support the use of emergency sclerotherapy for variceal bleeding in cirrhosis as the first, single treatment when compared with vasoactive drugs.
GastroenterologyValidity of randomized clinical trials in gastroenterology from 1964–2000
34 Citations2002Lise Lotte Kjaergard, Sarah L. Frederiksen +1 more
The present study shows a positive development, but the reported methodological quality of trials can still be improved.